Rishabh Instruments Q1FY27: consol PAT dips 1% YoY on higher tax; margin expands to 16.8%
PAT -1.31% YoY · revenue +4.18% · margins expanding
₹198.28 Cr
+4.18% YoY
₹19.36 Cr
-1.31% YoY
9.59%
-0.5pp YoY
₹4.93
Rishabh Instruments' consolidated Q1 FY27 (quarter ended June 30, 2026) revenue came in at ₹198.28 Cr, up a modest 4.2% YoY but down 3.2% sequentially from Q4 FY26's ₹204.86 Cr. Consolidated PAT of ₹19.36 Cr actually declined 1.3% YoY (from ₹19.62 Cr) and 3.3% QoQ — a mixed, broadly in-line print. No reliable current-quarter street estimate could be confirmed: web searches for a Q1 FY27 preview only surfaced stale coverage of last year's Q1 FY26 print (441% YoY profit jump, ₹5.13 EPS) — figures that in fact match this filing's year-ago comparative column, not the actual quarter under review — so vsStreet is left unknown rather than guessed.
Q1 FY-2027 vs prior quarters
The revenue-profit divergence traces to two offsetting forces below the operating line. EBITDA margin (revenue less operating costs, excluding finance cost and depreciation) expanded to 16.80%, up 188 bps YoY from 14.92% and 55 bps QoQ from 16.25% — genuine operating improvement, with PBT up 10.9% YoY to ₹26.57 Cr. But the effective tax rate jumped to 27.1% versus just 18.1% a year ago (27.4% last quarter, so this is now the norm rather than a blip, and above FY26's full-year 22.4% average), which erased the operating gains and left PAT lower than a year ago. Net profit margin was 9.77% — better than Q4 FY26's 9.50% but below the year-ago 10.08%, confirming tax, not revenue or cost, is the swing factor.
The stock went into the print at ₹648.65, down 1.6% over the past month of trading.
Management provided a positive outlook for FY27, projecting 20-25% growth in the EEI segment with EBITDA margins expected to remain between 20-22%. The Lumel Alucast business is targeted to reach near breakeven, with aspirations for double-digit margins in FY28. The company is investing in R&D and capacity expansion ac
— This quarter: met
Consolidated figures mask a sharp geographic divergence worth flagging given standalone and consolidated tell different stories here. Standalone (India) revenue grew 25.6% YoY to ₹77.60 Cr and PAT rose 20.1% YoY to ₹11.87 Cr (EPS ₹3.08 vs ₹2.57) — this maps to the Asia segment, up 21.1% YoY to ₹55.55 Cr, tracking within management's FY27 guidance of 20-25% growth for the EEI segment. Europe (Poland units including Lumel and Lumel Alucast), still 62.5% of group revenue, fell 8.0% YoY and 8.1% QoQ to ₹123.99 Cr, remaining the drag against the group's 20-22% EBITDA margin guidance — the 16.80% consolidated print is progressing toward but still below that band, consistent with Lumel Alucast not yet at its targeted near-breakeven contribution. Separately, Lumel SA won the Forbes Diamonds award for a second consecutive year (announced June 25, 2026) even as its segment's revenue line declined this quarter. No management press-release commentary on this specific result was available in the context to corroborate or contrast against these numbers.
W1
Europe segment (Poland units incl. Lumel Alucast) revenue fell 8.0% YoY to ₹123.99 Cr — watch for stabilization toward management's near-breakeven target for Lumel Alucast.
W2
Effective tax rate hit 27.1% this quarter vs 18.1% a year ago — watch whether it settles near FY26's full-year 22.4% average or stays structurally higher.
W3
Consolidated EBITDA margin at 16.80% remains below management's 20-22% FY27 guidance band — watch progression toward that range next quarter.
All figures converted from INR million to ₹ Cr (÷10). Consolidated PAT (₹19.364 Cr) is total profit for the quarter including non-controlling interests (₹0.338 Cr); owners' share is ₹19.026 Cr. Consolidated PBT includes ₹0.005 Cr share of associate profit. Six subsidiaries (₹38.71 Cr revenue, ₹2.71 Cr PAT) were reviewed by other auditors; one unreviewed subsidiary posted a ₹0.076 Cr net loss — both flagged as immaterial by management. Q4 FY26 comparative column is a derived 'balancing figure' per filing note, not separately audited as a standalone quarter.
EEI Explodes 34%, But Consolidated PAT Slips — Management Holds Guidance
The Electronics & Electrical Instruments segment crushed guidance with 34% growth and 24.8% EBITDA margins. Yet consolidated profit fell 1.3% YoY, and management deliberately chose not to raise full-year targets. The gap between segment strength and consolidated softness defines the quarter.
34%
vs 20-25% prior guidance
24.8%
vs 20-22% prior guidance
4.2%
₹198.3 Cr; soft
₹19.4 Cr
-1.3% YoY; down ₹30 L
On the surface, Rishabh Instruments delivered a confident quarter: the Electronics & Electrical Instruments segment — the growth engine — surged 34% with EBITDA margins expanding to 24.8%, well above the 20–22% guidance. Yet consolidated revenue growth limped to just 4.2%, and consolidated PAT fell despite top-line expansion. The reason is not complexity; it is segment drag. Lumel Alucast, the high-margin casting business, is in planned retreat (revenue down 41.2%, EBITDA negative 6.4%), and depreciation from the new Nashik facility added a ₹2 Cr headwind. Management's response to a decisive beat on the growth segment? Hold guidance and signal caution. That discipline, and what it implies about execution ahead, is the story.
Where the growth went — and didn't
The granular story is one of strength masked by planned weakness. Rishabh India (the core standalone business) grew 25.6%, powered by current transformers (data center wins + export), and delivered ₹11.9 Cr PAT (up 20.2% YoY). Lumel S.A., the European subsidiary, grew 39% with a 24% EBITDA margin and contributed ₹11.5 Cr PAT, up 321% YoY — a standout contributor despite subdued European macro. But Lumel Alucast (the precision-casting arm) remains in contraction: revenue fell 41.2%, EBITDA is negative ₹2.8 Cr (−6.4% margin), and PAT is down ₹5.9 Cr. This is intentional — management is rationalizing capacity while waiting for the RFQ pipeline to convert — but it is real drag on consolidated profit. Add in ₹2 Cr of depreciation from the Nashik facility (not yet fully productive), and consolidated PAT's 1.3% decline becomes unsurprising.
EEI grew 34% YoY, exceeding 20–25% guidance
Segment revenue 34% growth, EBITDA 69.1% YoY with 24.8% margin — confirmed.
Supported
Lumel S.A. grew 39% YoY with 24% EBITDA margin
₹63.9 Cr revenue, ₹15.3 Cr adjusted EBITDA (24%), ₹11.5 Cr PAT up 321% — confirmed.
Supported
Consolidated PAT down 1.3% YoY despite revenue growth
PAT ₹19.4 Cr vs ₹19.7 Cr prior year. Driven by ₹2 Cr depreciation increase + Alucast losses ₹5.9 Cr — confirmed.
Supported
Lumel Alucast operating breakeven in Q1
EBITDA still negative ₹2.8 Cr (−6.4% margin); operating breakeven not achieved. P&L shows PAT loss ₹5.9 Cr.
Overstated
Strong order bookings in India up ~20% YoY
Bookings up 20%, but billing not yet caught up. Revenue backlog building; timing risk if not realized next quarters.
Positive but timing-dependent
What changed on this call
Management's tone shifted on several fronts, and the shifts matter:
Alucast timeline extended. Prior calls suggested 'near breakeven.' Q1 shows negative 6.4% EBITDA. Now: double-digit margins in 2 years, with RFQ pipeline still in qualification stage (6+ month sales cycles post-award). A setback masked by confidence in the pathway.
Solar ambition upgraded dramatically. Prior guidance was vague; now explicit: ₹24–25 Cr this year (from <5% of India business), ramping to ₹250–300 Cr next year. That's 10x growth. Operational profitability achieved, but scaling to that magnitude (competing with Chinese players, ramping hybrid inverters) is execution-heavy.
US market targets sharpened. Now quantified at ₹45 Cr this year, ₹100 Cr in 2–3 years. Also opened to inorganic moves (M&A ₹50–200 Cr). Prior guidance was vaguer.
Data center wins quantified for the first time. 1 win announced, 3–4 additional wins in Q1, 10+ quotes pending. Represents near-term revenue catalyst for current transformers and validates AI/data center traction narrative.
The earnings quality: EBITDA grew, PAT fell
Consolidated EBITDA grew 17.3% YoY (a healthy number), but PAT declined 1.3%. The gap is entirely attributable to two items: (1) depreciation headwind of ₹2 Cr from the Nashik facility (new capex not yet fully productive), and (2) Alucast losses of ₹5.9 Cr (planned contraction while awaiting RFQ wins). Strip these two temporary drags, and the core business is delivering. But they are real costs, not accounting artifacts, and they will persist until capacity utilization accelerates. The depreciation burden especially will linger over the next 2–3 years as the facility ramps to full capacity. Sustainable PAT accretion hinges on (a) Alucast stabilization and (b) Nashik utilization reaching the 2.5x capacity design headroom.
Management's guidance refusal — what it signals
We really don't want to upscale guidelines. We want to keep our guidelines, which are already kind of aggressive, and beat them by performance.
The most telling moment on the call came when analysts pressed management on why they wouldn't raise guidance after a decisive 34% EEI beat. The refusal — framed as 'we want to keep our guidelines aggressive and beat them by performance' — signals two things. First, seasonality caution: management knows Q1 comparable is soft, and Q4 (which precedes it) was strong, so relative growth rates will compress. Second, macro conservatism: the call explicitly cited 'geopolitical uncertainties, tariff developments and supply chain volatility,' and management chose prudence over confidence. This is not overconfidence; it is discipline. But it also means management sees execution headwinds in the near term that the Q1 beat does not fully capture.
The bull-bear ledger
EEI segment 34% growth with margin expansion to 24.8% — multiple revenue engines (current transformers, data centers, Lumel wins, new geographies).
Lumel S.A. delivering 39% growth and 24% EBITDA margin, a standout even in subdued Europe, validating management's multi-revenue-stream strategy.
Data center AI traction explicitly quantified (1 win + 3–4 additional + 10+ quotes), opening a structural growth vector in India for current transformers.
Nashik facility buildout (2.5x capacity) provides a multi-year runway for organic growth without capex redeployment.
Balance sheet fortress: ₹160.6 Cr net cash, zero debt. Optionality for M&A (₹50–200 Cr) and organic investment.
Consolidated PAT fell 1.3% despite 4.2% revenue growth — quality of earnings under pressure from depreciation (₹2 Cr) and Alucast losses (₹5.9 Cr). PAT accretion will stall until both ease.
Lumel Alucast EBITDA still negative at −6.4%; management's claim of 'operating breakeven' was overstated. Recovery now 2 years out (double-digit margins by 2028), not 2027.
Customer concentration in Lumel S.A.: one German grid upgradation customer represents ~20–25% of segment revenue. Long-term project, but dependency risk remains.
Solar 10x growth target (₹24–25 Cr → ₹250–300 Cr in one year) is execution-heavy. Ramping manufacturing, hybrid inverter development, competition from Chinese players.
Depreciation headwind will persist 2–3 years as Nashik facility comes online. PAT growth will lag revenue growth until utilization ramps.
Risks, ranked by severity for a holder
Alucast RFQ conversion delays; sales cycles 6+ months post-award
HighAlucast revenue has already contracted 41.2% this quarter. Delays in converting RFQs push recovery timeline beyond the stated 2-year horizon, extending PAT headwind.
Lumel S.A. customer concentration on one German grid project (20–25% of revenue)
HighLong-term project (2–3 years more), but if customer reduces scope, finds alternate suppliers, or project stalls, Lumel S.A. growth (39% this quarter) could reverse sharply.
Depreciation burden persists 2–3 years as Nashik ramps to full 2.5x capacity
Medium₹2 Cr headwind in Q1. Until Nashik hits 60–70% utilization, depreciation will be a drag on consolidated PAT growth, potentially keeping it flat even as EBITDA grows.
Solar inverter 10x growth target (₹250–300 Cr next year) execution-dependent; ramping manufacturing, hybrid development, Chinese competition
MediumIf solar ramp stalls or competitive pricing pressure emerges, the segment could fail to deliver the ₹250–300 Cr target, missing a key growth vector.
Macro headwinds (Europe subdued, geopolitical, tariffs, supply chain volatility)
MediumManagement cited these explicitly. Consolidated growth of 4.2% vs. guidance of 20%+ suggests macro is already a drag. Further deterioration could compress margins or delay order bookings conversion.
How the street is positioned
The market validated the fundamental story despite headline PAT softness. The result was announced on 14 August at ₹648.65. By day 1, the stock had surged +7.08% (to ₹694.33) with 62.8% delivery, suggesting institutional conviction rather than retail enthusiasm. By day 3, the move held at +7.15%, reinforcing the message that the street understood the segment beat and Alucast drag, and priced them as temporary. Price is now at ₹684.2, just 6.25% below its all-time high and +117% off the 52-week low — a powerful recovery trajectory. Momentum is intact: volume is increasing, and RSI at 65.3 is neutral (not overbought), leaving room for further re-rating. FII ownership added a meaningful +1.08 percentage points to 1.18% (from 0.10% in the prior quarter), reversing a prior underweight and signaling foreign buying into the recovery. DII trimmed −0.52pp, likely locking profits after the strong run. Promoter holdings are stable at 69.40%, down fractionally from 69.55%, indicating no insider selling near the highs.
The street's positioning tells a clear story: the 34% EEI beat and Lumel strength are credible, and investors are willing to overlook Alucast and depreciation as temporary. The challenge for bulls is sustainability. The day-3 hold and FII inflow validate that the market believes management's conservative guidance was the right call — it left room for outperformance. Whether that outperformance materializes over H2 FY27 will determine whether the current re-rating holds.
The honest debate
1 · Alucast EBITDA trajectory and RFQ conversions
Q2 Alucast EBITDA should begin to stabilize (moving off the −6.4% Q1 base) if RFQ wins are starting to convert into production. Management must deliver on the claim that capacity ramp will restore double-digit margins. Any further deterioration or delay in RFQ conversion pushes recovery timeline beyond 2 years.
2 · Order bookings backlog conversion to revenue (Rishabh India segment)
Order bookings were up 20% YoY, but billing has not caught up. Q2–Q3 will show whether this backlog converts into sequential revenue growth. If it stalls, the India segment growth narrative faces a check.
3 · Data center order ramp and near-term revenue recognition
Management quantified 1 announced win, 3–4 additional wins, 10+ quotes pending. Q2–Q3 will show conversion rates and revenue recognition timelines. If data center wins accelerate, it validates the AI/scaling infrastructure thesis and could drive 30%+ growth in current transformers for the full year.
4 · Solar inverter production ramp and gross margins
Solar is targeting ₹24–25 Cr this year (₹6–6.25 Cr run-rate Q1), implying sequential ramp to ₹8+ Cr per quarter. Q2 will show whether production is scaling and whether gross margins are holding above 40% (target mix) as volumes ramp. Hybrid inverter development status update is also critical.
5 · Nashik facility utilization and depreciation burden relief
Full commissioning expected by September 2026. Q2–Q3 will show sequential revenue ramp from this facility and whether the ₹2 Cr depreciation headwind is being absorbed into higher utilization. Target is 2.5x capacity over 4–5 years — Q2 capex and utilization plans will guide the timeline.
The single number to track from here
Forget the segment splits for a moment. The number that matters is consolidated PAT — specifically, whether it accelerates from the −1.3% YoY Q1 print to positive YoY growth by Q3–Q4. If it does, the market's bet (that Alucast drag and depreciation are temporary) is vindicated, and the re-rating holds. If it stalls or goes more negative, the story reverses: segment strength is real, but consolidated profit remains under pressure, and the stock re-rates lower. Management's guidance discipline suggests they see that bar as achievable but not certain. Investors should watch Q2–Q3 for signs of PAT acceleration, not just EBITDA or segment growth. The 6–9 month outlook resolves on this one metric.
EEI boom masks soft consolidated print; guidance held
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Met FY-2026 expectations (overdelivered). Q1 beat EEI guidance but consolidated growth soft. Intentionally held guidance despite beat.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
EEI segment delivered a robust 34% growth with 24.8% EBITDA margins, significantly exceeding prior 20-25% guidance, underpinned by multiple revenue streams (current transformers, data centers, new geographies, Lumel's grid upgradation wins). However, consolidated revenue growth of just 4.2% and PAT decline of 1.3% YoY expose the drag from Lumel Alucast (down 41.2%, still negative EBITDA) and increased depreciation from the new Nashik facility. Management's explicit decision to hold guidance despite Q1 beat signals caution on sustainability. Multi-year opportunities (US scaling to ₹100 Cr, Alucast recovery in 2 years) are credible but 2-3 years out; key execution risk is concentrating 20-25% of Lumel's revenue with one German customer on a long-term project.
₹198.3 Cr
Revenue · +4.2% YoY₹19.4 Cr
Reported PAT · −1.3% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
EEI grew 34% YoY, exceeding 20-25% guidance
METSegment-level EEI revenue growth 34% confirmed; adjusted EBITDA margin 24.8% vs 20-22% prior guidance
Lumel S.A. grew 39% YoY with 24% EBITDA margin
METRevenue ₹63.9 Cr (+39%), adjusted EBITDA ₹15.3 Cr (24% margin), PAT ₹11.5 Cr up 321% YoY
Consolidated PAT down 1.3% YoY despite revenue growth
METPAT ₹19.4 Cr down from ₹19.7 Cr; driven by depreciation increase ₹20M and Alucast losses ₹5.9 Cr
Lumel Alucast operating breakeven in Q1 FY27
OVERSTATEDRevenue ₹44.3 Cr, adjusted EBITDA -₹2.8 Cr (negative 6.4%), PAT -₹5.9 Cr. Claim on operating breakeven unverifiable from P&L
Strong order bookings in India 20% upside YoY
MixedOrder bookings up ~20%, but billing not yet reflected (backlog building). No revenue recognition yet
Earnings quality
What changed since the last call
EEI guidance implicitly validated but not raised
NeutralManagement reaffirmed 20% EEI top-line growth and 20-22% EBITDA despite delivering 34% growth and 24.8% margin in Q1. Explicitly refused to raise guidance, citing seasonality and cautious macro outlook.
Alucast recovery timeline extended to 2 years
DowngradePrior call indicated 'near breakeven.' Q1 shows negative 6.4% EBITDA. Management now says double-digit margins in 2 years, implying sustained losses in FY27-FY28. RFQ pipeline in qualification stage (long cycles).
Solar business trajectory upgraded to ₹250-300 Cr next year
UpgradePrior ambition was vague. Now explicit: ₹24-25 Cr this year (from <5% prior), 10x to ₹250-300 Cr next year. Achieved operational profitability and ramping single-phase + launching 3-phase 12 kW range.
US market scaling commitment sharpened
UpgradeNow explicit: ₹30 Cr → ₹45 Cr this year → ₹100 Cr in 2-3 years. Also opened to inorganic moves (M&A ticket ₹50-200 Cr). Prior guidance was vaguer.
Data center opportunity explicitly quantified
New1 win announced, 3-4 additional wins in Q1, 10 more quotes. Order bookings up 20%. Represents near-term revenue catalyst for India segment current transformers.
The Q&A
Analysts pressed management hard on EEI's 34% vs 20-25% guided (Dhwanil Desai, Kiran). Management held the line: 'we don't want to raise guidelines...we want to keep our guidelines, which are already kind of aggressive, and beat them by performance.' Tone was patient but defensively cautious. Investors questioned Alucast viability (long sales cycles, RFQ backlogs) and Lumel customer concentration; management acknowledged but framed as opportunity (consolidation of suppliers) and risk-spread (multiple revenue streams in Lumel). No analyst directly challenged margins or macro outlook.
EEI growth drivers — Dhwanil Desai, Turtle Capital
AnsweredMultiple engines: current transformers (data center, solar), Rishabh India 25.6% growth, Lumel 39% growth from grid upgradation in Germany, new product launches. Not lumped. Sustainable growth spread across product and geography.
US market scaling — Dhwanil Desai, Turtle Capital
AnsweredOrganic: adding resources, Mexico added, Canada/South America planned. Inorganic: couple of opportunities under review, will announce when material. Target ₹100 Cr in 2-3 years.
Alucast recovery path — Dhwanil Desai, Turtle Capital
PartialStrong RFQ pipeline in qualification (slow process, 6 months ramp after award). Double-digit margins in 2 years. Consolidation of suppliers benefits us. Team committed, costs cut.
Q1 growth sustainability — Zaki Nasser, Individual Investor
PartialAbsolutely right observation. Q1 comparable to Q4 last year. Want to be careful with guidance. Will try to deliver more than our commitments. Please don't expect 34% every quarter.
AI and data center traction — Zaki Nasser, Individual Investor
AnsweredGood success. 1 first win announced, 3-4 more wins in Q1, 10 more quotes pending. Part of the story. Order bookings up 20% in Q1 vs last year.
Europe market outlook — Zaki Nasser, Individual Investor
AnsweredLumel grew 39% despite subdued Europe because of multiple revenue streams: radiation gates (security, airports), medium-voltage products, solar, grid upgradation in Germany (EUR5M + EUR3M orders + more to come). Market is huge, our % small. If we beat competition, we win.
M&A ticket size and strategy — Zaki Nasser, Individual Investor
Answered₹50 Cr to ₹150-200 Cr based on strategic fit. Looking at 4-5 opportunities. Due diligence process lengthy and thorough. Only business which is strategically good and ethically clean.
Lumel segment financials — Ankur Gulati, Genuity Capital
AnsweredRevenue ₹639 million, EBITDA ₹153 million, PAT ₹115 million.
Americas go-to-market strategy — Ankur Gulati, Genuity Capital
Answered30-40% organic growth ambition (delivered in last 2-3 years). Strategies: 1) Upgrade products for ANSI and UL certification, 2) Expand resources (sales, Canada/Mexico/Latin America), 3) Inorganic moves. Target ₹100 Cr in 2-3 years.
Solar inverter production readiness — Ankur Gulati, Genuity Capital
AnsweredNow selling in thousands (vs hundreds). Launched iNEO 3-phase up to 12 kW this quarter. Up to 50 kW by end of FY27. Hybrid inverters under development by end of FY27. Both direct distribution and EPC supply channels.
Nashik facility status — Ankur Gulati, Genuity Capital
AnsweredBoth buildings completed. Shifted and partially operational. Everything should be done in 1-2 months. Built for 2.5x production capacity over next 4-5 years.
Lumel large customer concentration — Kiran, TableTree Capital
PartialEUR5M already executed (not in Q1 revenue). EUR3M ongoing (~20-25% of sales, month-to-month through end of FY27, not one-time). But other growth too: radiation gates, chips, solar. Grid upgradation is long-term (2-3 years more projects). Customer enhanced with better solutions each order.
India growth drivers and margin moderation — Kiran, TableTree Capital
AnsweredSolar still <5% of business (₹24-25 Cr this year, targeting ₹250-300 Cr next year). Growth from traditional products. Solar + EMS have lower margins (15-20% contribution vs 40-45% average). White-label is our own design, so margins comparable to branded products.
FY27 EEI growth guidance confirmation — Kiran, TableTree Capital
DodgedReally don't want to upscale guidelines. Seasonality: July/Aug and Dec/Jan holidays in Europe, Diwali in India. Q1 like Q4 of last year. Will try to deliver more. Commitments: 20% top-line, 20-22% EBITDA. Don't want to give guidelines higher than necessary and risk.
Current transformer capacity and expansion — Mulesh Savla, Shah & Savla
AnsweredExpanding from 5,000-6,000 units/day to 8,000-10,000 (doubling). Using new Nashik facility + new machinery ordered. Also expanding to medium-voltage CTs. Work in progress.
PCB manufacturing and external supply — Mulesh Savla, Shah & Savla
Answered3 SMT lines, latest high-end. Making PCBAs for Intel motherboards (high-end PCBA family). Currently some spare capacity. Will add 4th line once 3 at full 3 shifts. This is part of EMS business growth.
Battery energy storage systems opportunity — Mulesh Savla, Shah & Savla
AnsweredNot direct battery manufacturing. Indirect via hybrid inverters. Battery management, automation solutions. Will be part of ecosystem but not battery makers themselves.
M&A pipeline status — Mulesh Savla, Shah & Savla
PartialExploring everywhere: US, Europe, India. Nothing at serious stage yet. Process thorough. Must be strategic fit and ethically sound.
Guidance
EEI FY27: ~20% top-line growth (reaffirmed from prior 20-25%)
HighAlready delivered 34% in Q1. Management attributes to multiple drivers (CTs, data centers, Lumel, new geographies). Explicitly refused to raise guidance despite beat.
US revenue: ₹45 Cr target FY27, ₹100 Cr in 2-3 years
MediumCurrently ₹30 Cr. Organic 30-40% growth + product upgrades (ANSI, UL) + inorganic moves planned. Product redesign for American market ongoing.
Solar inverters: ₹250-300 Cr next year (from ₹24-25 Cr this year)
Low10x growth target. Currently <5% of business. Ramping production, both direct and EPC channels. Hybrid inverter development underway. Execution risk.
Alucast: EBITDA breakeven by end FY27, double-digit margins in 2 years
MediumQ1 negative 6.4% EBITDA. RFQ pipeline in qualification stage (long sales cycles, 6 months post-award ramp). 20-25% of Lumel revenue from one German customer.
EEI EBITDA FY27: 20-22% (maintained from prior)
HighQ1 delivered 24.8% adjusted EBITDA, up 520 bps from 19.6%. Operating leverage, product mix, procurement efficiencies evident. Management confident on sustainability.
Consolidated EBITDA: 16.8% (OPM)
MediumDelivered in Q1. Supported by EEI + Lumel strength. Alucast drag ongoing. Depreciation headwind (₹20M Q1) will continue as facility ramps.
Nashik facility: Partial commissioning Q1, full by Sep 2026
HighBoth buildings completed. Shifted and partially operational. 2.5x capacity expansion targeted over 4-5 years.
CT capacity doubling: 5-6k to 8-10k units/day
HighNew Nashik facility + new machinery ordered. Work in progress. Medium-voltage expansion also planned.
PCB SMT lines: 4th line addition when 3 lines at 3 shifts full
MediumCurrently 3 SMT lines operational. One old line being upgraded. EMS business scaling gradually.
Risks the call surfaced
Customer concentration
HighLumel S.A. derives ~20-25% of revenue from EUR5M + EUR3M German grid upgradation orders. Project long-term (2-3 years) but customer concentration risk if project stalls or customer shifts suppliers.
Alucast recovery execution
HighLumel Alucast revenue down 41.2% (planned). EBITDA negative 6.4% in Q1. Management targeting EBITDA breakeven by FY27 end, double-digit margins in 2 years. RFQ pipeline in qualification/negotiation (slow process, 6+ month ramp post-award). Execution risk on both converting RFQs and operationalizing capacity.
Macro and geopolitical uncertainty
MediumCall explicitly mentions 'geopolitical uncertainties, tariff developments and supply chain volatility.' Europe 'relatively subdued' environment. Q1 consolidated revenue growth only 4.2% despite segment strength, suggesting macro headwinds. US tariff risks unmentioned but relevant.
Solar inverter scaling risk
MediumSolar inverters targeting ₹250-300 Cr next year (from ₹24-25 Cr this year, <5% of India business currently). Requires manufacturing scale-up (new facility dedicated floor), market adoption, competitive wins vs Chinese players. Achieved operational profitability but volumes still ramping.
Depreciation headwind on PAT
MediumDepreciation increased ₹20M in Q1 from new facility. EBITDA grew 17.3% YoY but consolidated PAT declined 1.3%. As facility reaches full capacity (4-5 years), depreciation burden will persist unless revenue growth accelerates significantly.
Management
Score 7/10. Clear on segment drivers and numbers. Disciplined on guidance (explicitly refused to raise despite beat). Good transparency on risks (Alucast recovery timeline, customer concentration, macro headwinds). Some vagueness on M&A and inorganic opportunities (exploring but 'nothing serious'). Strong track record on EEI and Lumel S.A. (beat guidance). Alucast recovery extended (now 2 years for double-digit margins vs prior 'near breakeven'). Nashik facility on track. Product launches on schedule (solar 10-15 products per year, inverters). Over-delivered last year, confident they'll repeat.
1 · Sep 2026
Nashik facility full commissioning; capacity ramp begins
2 · Q2 FY27
Order bookings backlog converts to revenue; India segment growth accelerates
3 · FY27 end
Lumel Alucast EBITDA breakeven; Hybrid inverter ramp to production
Multi-year opportunities (US scaling to ₹100 Cr, Alucast recovery in 2 years) are credible but 2-3 years out; key execution risk is concentrating 20-25% of Lumel's revenue with one German customer on a long-term project.